乌帕替尼治疗儿童克罗恩病1例

潘桂贤, 杨秋萍, 杨喜媚, 蔡尧, 李思涛

中国当代儿科杂志 ›› 2026, Vol. 28 ›› Issue (3) : 342-345.

PDF(1077 KB)
HTML
PDF(1077 KB)
HTML
中国当代儿科杂志 ›› 2026, Vol. 28 ›› Issue (3) : 342-345. DOI: 10.7499/j.issn.1008-8830.2508046
病例报告

乌帕替尼治疗儿童克罗恩病1例

作者信息 +

A case report of Crohn's disease in a child treated with upadacitinib

Author information +
文章历史 +

摘要

患儿,男,12岁,反复腹痛5月余,肛周肿块10 d。胃肠镜检查显示回肠末端、结肠多发溃疡,结合组织病理学结果,该患儿诊断为克罗恩病。患儿合并特应性皮炎,既往已使用乌帕替尼治疗,诊断克罗恩病后,继续使用乌帕替尼治疗,共随访100周。随访期间,患儿维持临床缓解,未见严重不良反应。该病例为国内首次关于乌帕替尼治疗儿童克罗恩病的报道,对乌帕替尼治疗儿童克罗恩病具有指导意义。

Abstract

A 12-year-old boy presented with recurrent abdominal pain for more than 5 months and a perianal mass for 10 days. Gastrointestinal endoscopy revealed multiple ulcers in the terminal ileum and colon, and Crohn's disease was diagnosed based on histopathology. The patient had atopic dermatitis and had previously received upadacitinib; after the diagnosis of Crohn's disease, upadacitinib was continued. During a total follow-up of 100 weeks, the patient maintained clinical remission without serious adverse reactions. This is the first report from China on upadacitinib treatment for pediatric Crohn's disease and provides guidance for its use in this population.

关键词

克罗恩病 / 乌帕替尼 / 长期随访 / 儿童

Key words

Crohn's disease / Upadacitinib / Long-term follow-up / Child

引用本文

导出引用
潘桂贤, 杨秋萍, 杨喜媚, . 乌帕替尼治疗儿童克罗恩病1例[J]. 中国当代儿科杂志. 2026, 28(3): 342-345 https://doi.org/10.7499/j.issn.1008-8830.2508046
Gui-Xian PAN, Qiu-Ping YANG, Xi-Mei YANG, et al. A case report of Crohn's disease in a child treated with upadacitinib[J]. Chinese Journal of Contemporary Pediatrics. 2026, 28(3): 342-345 https://doi.org/10.7499/j.issn.1008-8830.2508046

参考文献

[1]
Loftus EV, Panés J, Lacerda AP, et al. Upadacitinib induction and maintenance therapy for Crohn's disease[J]. N Engl J Med, 2023, 388(21): 1966-1980. DOI: 10.1056/NEJMoa2212728 .
[2]
Peyrin-Biroulet L, Louis E, Loftus EV, et al. Quality of life and work productivity improvements with upadacitinib: phase 2b evidence from patients with moderate to severe Crohn's disease[J]. Adv Ther, 2021, 38(5): 2339-2352. PMCID: PMC8107073. DOI: 10.1007/s12325-021-01660-7 .
[3]
D'Haens G, Panés J, Louis E, et al. Upadacitinib was efficacious and well-tolerated over 30 months in patients with Crohn's disease in the CELEST extension study[J]. Clin Gastroenterol Hepatol, 2022, 20(10): 2337-2346.e3. DOI: 10.1016/j.cgh.2021.12.030 .
[4]
Clement B, De Felice K, Afzali A. Indications and safety of newer IBD treatments in the older patient[J]. Curr Gastroenterol Rep, 2023, 25(7): 160-168. PMCID: PMC10209934. DOI: 10.1007/s11894-023-00874-9 .
[5]
Paller AS, Ladizinski B, Mendes-Bastos P, et al. Efficacy and safety of upadacitinib treatment in adolescents with moderate-to-severe atopic dermatitis: analysis of the measure up 1, measure up 2, and AD up randomized clinical trials[J]. JAMA Dermatol, 2023, 159(5): 526-535. PMCID: PMC10099102. DOI: 10.1001/jamadermatol.2023.0391 .
[6]
Patruno C, Lauletta G, Pezzolo E, et al. Effectiveness and safety of upadacitinib for adolescents with atopic dermatitis in a real-world setting[J]. Clin Drug Investig, 2024, 44(8): 629-634. DOI: 10.1007/s40261-024-01382-y .
[7]
Collen LV. Rapid clinical remission with upadacitinib in a pediatric patient with refractory Crohn's disease[J]. Inflamm Bowel Dis, 2023, 29(7): 1175-1176. DOI: 10.1093/ibd/izad048 .
[8]
Spencer EA, Bergstein S, Dolinger M, et al. Single-center experience with upadacitinib for adolescents with refractory inflammatory bowel disease[J]. Inflamm Bowel Dis, 2024, 30(11): 2057-2063. PMCID: PMC12102471. DOI: 10.1093/ibd/izad300 .
[9]
Liu Y, Song X, Xiang L, et al. Rapid remission with upadacitinib in a child with refractory Crohn's disease and ATM mutation: a case report[J]. Curr Ther Res Clin Exp, 2024, 101: 100756. PMCID: PMC11385748. DOI: 10.1016/j.curtheres.2024.100756 .
[10]
Bousvaros A, Schmidt BAR, Kurtz M. Treatment of genital Crohn's disease with upadacitinib in a male child: a case report[J]. Gastroenterol Hepatol (N Y), 2023, 19(7): 401-403. PMCID: PMC10524414.

脚注

所有作者声明无利益冲突。


版权

版权所有 © 2023中国当代儿科杂志
PDF(1077 KB)
HTML

Accesses

Citation

Detail

段落导航
相关文章

/